Takeda Pharmaceutical Company

Results: 76



#Item
61Tegernsee Symposium – focused on Grace Period Tegernsee Offices: JPO, USPTO, EPO, UKIPO, DPMA, INPI, DKPTO Thursday, July 10, 2014 Tokyo (Heian Room, Hotel Okura Tokyo)

Tegernsee Symposium – focused on Grace Period Tegernsee Offices: JPO, USPTO, EPO, UKIPO, DPMA, INPI, DKPTO Thursday, July 10, 2014 Tokyo (Heian Room, Hotel Okura Tokyo)

Add to Reading List

Source URL: www.jpo.go.jp

Language: English - Date: 2014-07-23 00:11:14
62Microsoft Word[removed] ロゴ入りUpdated information about pioglitazone and increased risk of bladder cancer.doc

Microsoft Word[removed] ロゴ入りUpdated information about pioglitazone and increased risk of bladder cancer.doc

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2011-10-26 22:02:25
63UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA In re Actos (Pioglitazone) Product Liability Litigation This Document Applies to:

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA In re Actos (Pioglitazone) Product Liability Litigation This Document Applies to:

Add to Reading List

Source URL: www.lawd.uscourts.gov

Language: English - Date: 2014-06-18 10:11:19
64UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA In re Actos (Pioglitazone) Product Liability Litigation This Document Applies to:

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA In re Actos (Pioglitazone) Product Liability Litigation This Document Applies to:

Add to Reading List

Source URL: www.lawd.uscourts.gov

Language: English - Date: 2014-06-18 10:09:53
65FOR IMMEDIATE RELEASE Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes Gaithersburg, MD, October 11, 2012 – Zyngenia, Inc., a biopharmaceutica

FOR IMMEDIATE RELEASE Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes Gaithersburg, MD, October 11, 2012 – Zyngenia, Inc., a biopharmaceutica

Add to Reading List

Source URL: www.zyngenia.com

Language: English - Date: 2013-06-10 17:55:59
66Tegernsee Symposium – focused on Grace Period Tegernsee Offices: JPO, USPTO, EPO, UKIPO, DPMA, INPI, DKPTO Thursday, July 10, 2014 Tokyo (Heian Room, Hotel Okura Tokyo)

Tegernsee Symposium – focused on Grace Period Tegernsee Offices: JPO, USPTO, EPO, UKIPO, DPMA, INPI, DKPTO Thursday, July 10, 2014 Tokyo (Heian Room, Hotel Okura Tokyo)

Add to Reading List

Source URL: www.jpo.go.jp

Language: English - Date: 2014-07-23 00:11:14
67Úrskurður Einkaleyfastofunnar í andmælamáli nr[removed]Takeda Pharmaceutical Company Limited, Japan gegn

Úrskurður Einkaleyfastofunnar í andmælamáli nr[removed]Takeda Pharmaceutical Company Limited, Japan gegn

Add to Reading List

Source URL: www.els.is

Language: Norwegian - Date: 2010-06-18 11:45:49
    68Ákvörðun Einkaleyfastofu í andmælamáli nr[removed]Takeda Pharmaceutical Company Limited gegn

    Ákvörðun Einkaleyfastofu í andmælamáli nr[removed]Takeda Pharmaceutical Company Limited gegn

    Add to Reading List

    Source URL: www.els.is

    Language: Norwegian - Date: 2009-02-02 12:11:20
      69News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Companies Submit Joint Application Seeking Approval for Additional Indication for

      News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Companies Submit Joint Application Seeking Approval for Additional Indication for

      Add to Reading List

      Source URL: www.mt-pharma.co.jp

      Language: English - Date: 2012-08-31 03:11:29
      70News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Helicobacter pylori Gastritis Approved as Additional Indication in Japan for Helicobacter pylori

      News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Helicobacter pylori Gastritis Approved as Additional Indication in Japan for Helicobacter pylori

      Add to Reading List

      Source URL: www.mt-pharma.co.jp

      Language: English - Date: 2013-02-20 20:53:02